Report from Thailand - The Thai government is ramping up efforts to promote and develop the biotechnology sector in a bid to enhance its global competitiveness. - BioPharm International

ADVERTISEMENT

Report from Thailand
The Thai government is ramping up efforts to promote and develop the biotechnology sector in a bid to enhance its global competitiveness.


BioPharm International
Volume 26, Issue 4, pp. 8-9

IMPORTANT FACTS

  • Under Thailand's first National Biotechnology Policy Framework (2004 to 2009), 90 new companies were formed, bringing the number of biotech companies to an estimated total of 170.
  • Thailand has succeeded in producing the world's first commercial biosensor for avian influenza. Currently, it is in the process of producing its first indigenous drug to treat malaria. If successful, it will be a breakthrough development that puts Thailand on the world map.
  • Thailand is regarded as a prime "pharmerging market" due to the potential of its biotech sector. The large population and academic/healthcare infrastructure make the country an ideal provider of clinical trials.

—Jane Wan is a freelance writer based in Singapore.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here